Genetic Testing Company Assessment
Clinical Diagnostics
400+
4
Target Identification
Objective
A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition
Our Approach
Primary Research
- Conducted 4 supplementary KOL interviews to assist in company deep dives
Secondary Research
- Collated a list of 400+ U.S. genetic testing laboratories from public sources (e.g., databases, press releases, news), narrowing the list down to 10 identified candidates based on viability
- Conducted deep dives into the 4 most attractive potential targets
Outcome
DeciBio narrowed a pool of 400+ U.S. laboratories down to 4 high priority potential targets, then profiled each, including information such as:
- Annual test volumes
- Valuation
- Portfolio breadth
- Test performance
- Analysis of opportunities and drawbacks
Related Client Results
Cell Therapy Market Trends and Revenue Forecast
Revenue Projection
RNA-based Oncology Biomarker Market Landscape
Voice-of-Customer Research
Competitive Analysis
Biomarker and Diagnostics Strategy
Product Specification Mapping
Infectious Pathogen Diagnostics Technology Commercialization
Voice-of-Customer Research
